Risk that upfront investments in growth areas such as nutraceuticals and digital transformation may fail to generate returns or result in competitive disadvantage due to poor investment choices or insufficient investment. This also covers investment decisions and ongoing oversight, including investment IRR, payback periods and post-implementation monitoring.